SCHEMBL17488409

SCHEMBL17488409

Cc1ccc(-c2ccc(C(=O)OCCOCc3ccccc3)cc2OCCOCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
FFAR4 Q5NUL3 1/20 0.46
HTR7 P34969 1/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
EGFR P00533 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20033180 0.89 GSTP1 (0.48) CYP11B1CYP11B2LMNAMAPTALDH1A1
SCHEMBL17488410 0.89 ALDH1A1 (0.39) CYP11B1CYP11B2FFAR4HTR7LMNA
SCHEMBL17488407 0.87 ALDH1A1 (0.44) HTR7LMNAMAPTALDH1A1NPC1
SCHEMBL18441971 0.82 ESR1 (0.47) HTR7LMNAMAPTALDH1A1NPC1
SCHEMBL18621853 0.81 ESR1 (0.49) LMNAMAPTALDH1A1NPC1RAB9A
SCHEMBL16351942 0.80 L3MBTL1 (0.46) HTR7LMNAMAPTNPC1RAB9A
SCHEMBL18442153 0.80 PTGER4 (0.43) MAPTALDH1A1RAB9AL3MBTL1RXRA
SCHEMBL28211516 0.80 MAPT (0.54) HTR7LMNAMAPTALDH1A1NPC1
SCHEMBL17488408 0.79 ESR1 (0.47) FFAR4HTR7LMNAMAPTALDH1A1
SCHEMBL17488411 0.79 ALDH1A1 (0.40) CYP11B1CYP11B2HTR7LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938229-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2018-04-10 US disclosed
US-20160032189-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160032189-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, ILK, LCP1 CYP11B1 4179/4885CYP11B2 3930/4885FFAR4 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.